Lead sponsor
Attikon Hospital
4 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
4
Trials led
3
Active
330
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Not applicable
4
Trials by status
Recruiting
2
Active, not recruiting
1
Unknown
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Cardiovascular and Endothelial Markers During OGTT Before and at Six and Twelve Months Post-treatment in Women With PCOSFemalenot applicableRecruiting120
The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and AlbuminuriaHbA1c 7-10%not applicableActive, not recruiting60